FULC
Fulcrum Therapeutics Inc
3.70$
+0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | |
| 2,402.9% | 58.3% | – | 21.6% | – | – | – | – | – | – | – | – | – | |
| -2,302.9% | 41.7% | – | 78.4% | – | – | – | – | – | – | – | – | – | |
| 2,402.9% | 2,181.3% | – | 21.6% | – | – | – | – | – | – | – | – | – | |
| 1,228.1% | 1,132.5% | – | 12.5% | – | – | – | – | – | – | – | – | – | |
| 1,312.4% | 3,255.5% | – | 12.8% | – | – | – | – | – | – | – | – | – | |
| -3,615.3% | -3,213.8% | – | 65.6% | – | – | – | – | – | – | – | – | – | |
| – | 362.9% | – | – | – | – | – | – | – | – | – | – | – | |
| -3,164.3% | -2,842.3% | – | 69.3% | – | – | – | – | – | – | – | – | – | |
| 53.9% | 362.9% | – | – | – | – | – | – | – | – | – | – | – | |
| -3,164.3% | -2,842.3% | – | 69.3% | – | – | – | – | – | – | – | – | – | |
| -3,094.3% | -2,783.9% | – | 69.7% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.